All News

    FDA Approves GRAFAPEX/Fludarabine Before alloHSCT in AML and MDS

    January 24th 2025, 4:15pm

    Article

    The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome prior to alloHSCT.

    Whitesnake Guitarist John Sykes Died of Cancer, Mike Peters Starting CAR-T

    January 24th 2025, 4:00pm

    Article

    From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s this week’s cancer news.

    Opdivo Regimen May Prolong Survival in Chinese Patients With Certain GI Cancers

    January 24th 2025, 2:00pm

    Article

    Opdivo plus chemo showed long-term survival advantages in Chinese patients with advanced gastric, gastroesophageal junction or esophageal cancer.

    Opdivo Plus Chemo Shows 5-Year Efficacy in Gastric, GEJ and Esophageal Cancer

    January 23rd 2025, 10:15pm

    Article

    Among patients with advanced gastric and GEJ cancer, or esophageal adenocarcinoma, treatment with first-line Opdivo and chemo demonstrated deep responses.

    SHR-1701 Combo Reduces Chemo-Related Myelosuppression in Gastric/GEJ Cancer

    January 23rd 2025, 9:35pm

    Article

    SHR-1701 plus chemo suppressed chemo-associated myelosuppression in patients with HER2-negative gastric or gastroesophageal junction adenocarcinoma.

    Afinitor Plus Somatuline Prolongs Survival in GEP-NETs

    January 23rd 2025, 7:00pm

    Article

    Afinitor plus Somatuline showed an improved survival compared with Afinitor monotherapy in patients with gastroenteropancreatic neuroendocrine tumors.

    Matching Patient Needs with Oncologists’ Strengths in Cancer Care

    January 23rd 2025, 6:02pm

    Article

    Following a lung cancer diagnosis, I learned that it is important to ask oncologists thoughtful questions to know if they are the best doctor for my needs.

    The FDA Accepts a BLA for RP1 Plus Opdivo in Advanced Melanoma

    January 23rd 2025, 4:00pm

    Article

    The FDA has accepted a BLA for treatment with RP1 in combination with Opdivo for patients with advanced melanoma who have progressed on prior therapy.

    Driving Awareness, Action and Empowerment During Cervical Cancer Awareness Month

    January 23rd 2025, 2:00pm

    Article

    Dr. Ritu Salani discussed Cervical Cancer Awareness Month, highlighting what patients with this disease should be aware of as well as prevention tactics.

    Feeding Souls: A Cancer Journey Through the Lens of Food

    January 22nd 2025, 10:00pm

    Article

    I've learned that cooking for friends during their cancer journey is a way to express love and support, even if it doesn't cure them.